Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear Receptor Subfamily 4 Group A Member 2 (NR4A2)
- Target
- NR4A2
- Molecular classification
- Nuclear receptor, Transcription factor, Orphan nuclear receptor
01
Overview
NR4A2, also known as NURR1, is an orphan nuclear receptor and transcription factor crucial for the development, maintenance, and survival of midbrain dopaminergic neurons. It regulates gene expression by binding to specific DNA response elements and is implicated in several disorders, including Parkinson’s disease, Alzheimer’s disease, schizophrenia, and rheumatoid arthritis. It is considered a potential therapeutic target, but no approved therapies currently exist targeting this pathway directly.
- Other names
- NURR1nuclear receptor related 1 protein
02
Mechanism of action
Modulation of NR4A2 activity via small molecules or co-regulator interactions (research ongoing)
03
Biological functions
Dopaminergic neuron differentiationDopaminergic neuron survivalTranscriptional regulationGene expression
04
Disease associations
Neurodevelopmental DisordersNeurodegenerative DiseasesParkinson’s diseaseAlzheimer’s diseaseSchizophreniaRheumatoid arthritisAutoimmune diseasesInflammatory diseases
05
Safety considerations
Potential for off-target effects due to broad expression profileChallenges in developing specific ligands for an orphan receptor
Beyond the preview
Go deeper on Nuclear Receptor Subfamily 4 Group A Member 2 (NR4A2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nuclear Receptor Subfamily 4 Group A Member 2 (NR4A2).